Literature DB >> 9158579

Cognitive markers preceding Alzheimer's dementia in the healthy oldest old.

D B Howieson1, A Dame, R Camicioli, G Sexton, H Payami, J A Kaye.   

Abstract

OBJECTIVE: To look for preclinical markers of Alzheimer's dementia in a sample of healthy, oldest old individuals.
DESIGN: Prospective, longitudinal study of individuals examined at yearly intervals with neuropsychological tests selected to be sensitive to the early detection of dementia. PARTICIPANTS: One hundred and thirty-nine community-dwelling, functionally independent, healthy individuals 65 to 106 years of age who met strict criteria for lack of dementia at entry. Incident dementia cases consisted of 16 volunteers all 80 years old or older who developed dementia of the Alzheimer's type and 31 volunteers 80 years old and older showing no evidence of dementia during a mean 2.8-year follow-up interval. MEASUREMENTS: Scores on 10 neuropsychological measures were analyzed for the initial examination when none of the volunteers showed clinical evidence of dementia and for the two subsequent yearly examinations.
RESULTS: Individuals who subsequently developed dementia showed evidence of verbal memory impairment at their initial examination, which was a mean of 2.8 years before clinical evidence of dementia. The average yearly incidence rate for dementia in those 80 years of age and older was 12%. Performance of individuals who did not development dementia remained relatively stable during follow-up for up to 5 years.
CONCLUSION: Alzheimer's disease has a preclinical stage in which verbal memory decline is the earliest sign. Dementia in the oldest old is distinguishable from age-related cognitive decline.

Entities:  

Mesh:

Year:  1997        PMID: 9158579     DOI: 10.1111/j.1532-5415.1997.tb03091.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  35 in total

Review 1.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

2.  Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

Authors:  B C Dickerson; T R Stoub; R C Shah; R A Sperling; R J Killiany; M S Albert; B T Hyman; D Blacker; L Detoledo-Morrell
Journal:  Neurology       Date:  2011-04-13       Impact factor: 9.910

3.  Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response.

Authors:  S Duke Han; Wes S Houston; Amy J Jak; Lisa T Eyler; Bonnie J Nagel; Adam S Fleisher; Gregory G Brown; Jody Corey-Bloom; David P Salmon; Leon J Thal; Mark W Bondi
Journal:  Neurobiol Aging       Date:  2006-01-24       Impact factor: 4.673

Review 4.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

5.  Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype.

Authors:  Kelly L Lange; Mark W Bondi; David P Salmon; Douglas Galasko; Dean C Delis; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

6.  Tracking discourse complexity preceding Alzheimer's disease diagnosis: a case study comparing the press conferences of Presidents Ronald Reagan and George Herbert Walker Bush.

Authors:  Visar Berisha; Shuai Wang; Amy LaCross; Julie Liss
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 7.  The neuropsychological profile of Alzheimer disease.

Authors:  Sandra Weintraub; Alissa H Wicklund; David P Salmon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 8.  Early neuropsychological detection of Alzheimer's disease.

Authors:  C Bastin; E Salmon
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

9.  Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery.

Authors:  Jane B Tornatore; Emory Hill; Jo Anne Laboff; Mary E McGann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

10.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.